Brief: Dyadic And Medytox To Develop Vaccines Against COVID-19 Variants

Dyadic International

22/03/2021 12:50

March 22 (Reuters) - Dyadic International Inc  DYAI.O :
    * DYADIC INTERNATIONAL INC -
    * DYADIC AND MEDYTOX TO DEVELOP VACCINES AGAINST COVID-19
VARIANTS
    * DYADIC INTERNATIONAL - MEDYTOX, CO TO CO-DEVELOP C1
ENABLED
COVID-19 VACCINES AND/OR BOOSTERS
    * DYADIC INTERNATIONAL - MANUFACTURING PROTOCOLS TO PRODUCE
VACCINES FROM C1 HAVE BEEN SUCCESSFULLY TRANSFERRED AND
REPRODUCED AT MEDYTOX
    * DYADIC INTERNATIONAL - C1 MANUFACTURED COVID-19 VACCINES
AND/OR
BOOSTERS TO, IF SUCCESSFUL, BE USED TO IMMUNIZE PEOPLE AGAINST 2
OR MORE CURRENT, FUTURE COVID-19 VARIANTS

Source text for Eikon:  ID:nGNX3y7ppF 
Further company coverage:  DYAI.O 

 ((Reuters.Briefs@thomsonreuters.com;))